Skip to content

Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia

Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03471013
Acronym
CroyAid-SCZ
Enrollment
50
Registered
2018-03-20
Start date
2018-03-20
Completion date
2026-02-02
Last updated
2026-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DSM-5 Schizophrenia

Keywords

schizophrenia, beliefs, caregiver

Brief summary

Only one third of patients with schizophrenia are observant to their treatment knowing that the lack of adherence to treatment is one of the most important predictors of relapse. Recent work shows that the erroneous or negative beliefs of patients with schizophrenia regarding antipsychotic treatment are associated with poor compliance. The hypothesis is that negative beliefs about the antipsychotic treatment of caregivers of patients with schizophrenia may be associated with a higher risk of poor compliance compared to caregivers with positive beliefs about treatment. The primary purpose is to explore the correlation between caregiver beliefs about treatment and patient compliance, taking into account the level of caregiver-patient link.

Detailed description

Non-interventional cross-sectional exploratory study with a single visit for patients with schizophrenia and their caregivers, who agreed to participate in the protocol.

Interventions

None listed

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient over 18 years old * With a diagnosis of schizophrenia according to DSM-5 criteria * Accompanied by his main caregiver, who will be able to complete the questionnaires after having signed the information form. * Treated with one or more antipsychotics. * Able to complete the questionnaires related to the protocol * Having agreed to sign the information form.

Exclusion criteria

* Not understanding French, unable to answer questions linguistically * Presenting an organic pathology and / or cognitive deterioration likely to hinder a good understanding of the interview * Having already participated in the study * presenting disorders related to the use of substances of severe intensity (such as acute intoxication, withdrawal syndrome or any state of delirium)

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the correlation between caregiver beliefs about treatment and patient complianceAt day 1The caregiver beliefs are evaluated by the Beliefs about Medicines Questionnaire, the patient compliance is evaluated by the investigator with Behaviourally Anchored Rating Scales and by the patient him-self with Morisky Medication Adherence Scale, and the level of caregiver-patient link is evaluated with Involvement Evaluation Questionnaire.

Countries

France

Contacts

PRINCIPAL_INVESTIGATORLudovic SAMALIN

University Hospital, Clermont-Ferrand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026